Pediatric Glaucoma in a University Hospital

Mohamad Dakroub1, Diana Khair1, Bahaa' Noureddine1

  • 1Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Governorate, Lebanon.

Insights

Pediatric glaucoma patients, including primary congenital glaucoma (PCG) and secondary glaucoma, showed good intraocular pressure control. PCG eyes had a better visual prognosis despite earlier presentation and higher initial IOP.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Glaucoma Research

Background:

  • Pediatric glaucoma is a significant cause of vision loss in children.
  • Limited data exists on pediatric glaucoma characteristics in the Middle East.
  • Understanding differences between primary congenital glaucoma (PCG) and secondary glaucoma is crucial for management.

Purpose of the Study:

  • To describe the characteristics and outcomes of pediatric glaucoma patients in a Lebanese university hospital.
  • To compare outcomes between PCG and secondary glaucoma.
  • To identify factors influencing visual prognosis in pediatric glaucoma.

Main Methods:

  • Retrospective review of 64 eyes from 40 pediatric glaucoma patients with ≥1 year follow-up.
  • Analysis of intraocular pressure (IOP) control, best-corrected visual acuity (BCVA), and angle surgery failure rates.
  • Comparison of parameters between PCG and secondary glaucoma groups.

Main Results:

  • PCG eyes presented earlier with higher initial IOP and underwent earlier surgery than secondary glaucoma eyes.
  • Overall, 85.9% achieved good IOP control, but only 44.4% had BCVA ≥20/50.
  • PCG eyes showed a better visual prognosis; secondary glaucoma eyes required more medications and had poorer visual outcomes associated with later surgery, unilateral disease, and multiple procedures.

Conclusions:

  • Pediatric glaucoma patients, particularly PCG, present earlier with higher IOP and require timely surgery.
  • Both PCG and secondary glaucoma can achieve good IOP control, but PCG offers a superior visual outcome.
  • Factors like delayed surgery, unilateral disease, and multiple interventions negatively impact visual prognosis in secondary glaucoma.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
998
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
769
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
898
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
34